SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Cadila gets nod to sale stake in WHPL

16 Apr 2020 Evaluate

Zydus Cadila’s board of directors has approved and signed the Definitive Agreement for sale of 9,44,233 equity shares of Rs 10 each fully paid-up, representing 2% of the total paid-up share capital of Windlas Healthcare (WHPL), a subsidiary company to Windlas Biotech (WBPL).

Upon completion of the transaction in relation to the sale of the said equity shares, the total shareholding of the Company in WHPL will reduce to 49.00% from 51.00% and WHPL will cease to be the subsidiary of the company.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

 

Zydus Lifesciences Share Price

938.90 -1.20 (-0.13%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×